Rossari Biotech Limited (ROSSARI) — Cash Flow Reinvestment Rate

Latest as of December 2023: 0.00x

Rossari Biotech Limited (ROSSARI) has a Cash Flow Reinvestment Rate of 0.00x as of December 2023, reinvesting Rs0.00 (capex Rs0.00 ) from operating cash flow of Rs301.76 Million. Check Rossari Biotech Limited earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

0.00x
(Capex + Investments) / Operating CF

Total Reinvested

Rs0.00
Capex + Investments

Operating Cash Flow

Rs301.76 Million
INR

Capital Expenditures

Rs0.00
INR

Rossari Biotech Limited Cash Flow Reinvestment Rate (2017–2025)

Historical reinvestment intensity for Rossari Biotech Limited across 9 annual periods. Explore Rossari Biotech Limited (ROSSARI) cash flow to debt to assess how comfortably operating cash covers total debt obligations.

Annual Cash Flow Reinvestment Rate for Rossari Biotech Limited (2017–2025)

Year-by-year capital reinvestment analysis for Rossari Biotech Limited. For live market cap and broader valuation context, see market cap of Rossari Biotech Limited.

Year Reinvestment Rate Total Reinvested (INR) Operating CF Capex YoY Change
2025 2.49x Rs3.42 Billion Rs1.37 Billion Rs1.59 Billion ▼ -54.1%
2024 5.42x Rs2.34 Billion Rs432.55 Million Rs1.31 Billion ▲ +286.5%
2023 1.40x Rs2.14 Billion Rs1.52 Billion Rs328.76 Million ▼ -65.2%
2022 4.03x Rs1.18 Billion Rs293.58 Million Rs382.25 Million ▲ +147.7%
2021 1.62x Rs776.15 Million Rs477.67 Million Rs580.84 Million ▼ -53.6%
2020 3.50x Rs1.92 Billion Rs548.28 Million Rs759.71 Million ▲ +389.1%
2019 0.72x Rs509.30 Million Rs711.77 Million Rs439.91 Million ▼ -12.2%
2018 0.81x Rs208.36 Million Rs255.69 Million Rs139.25 Million ▼ -64.7%
2017 2.31x Rs108.23 Million Rs46.95 Million Rs39.12 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow